Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Difference between irbesartan and olmesartan in ameliorative effect on gestational hypertension in rats

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: NISHIMURA, Tomohiro (Keio University, Faculty of Pharmacy, Tokyo, Japan)
  • Co-author(s): Tomohiro Nishimura: Faculty of Pharmacy, Keio University, Tokyo, Japan
    Kyohei Fujimoto: Faculty of Pharmacy, Keio University, Tokyo, Japan
    Masatoshi Tomi: Faculty of Pharmacy, Keio University, Tokyo, Japan
  • Abstract:

    Backgrounds

    Gestational hypertension is a common disease in pregnant women but drug treatment is limited since most of antihypertension drugs are contraindicated. Angiotensin II receptor blockers (ARBs) are contraindicated due to risk of oligohydramnios. According to our preliminary research using FDA-AERS, however, ARBs can be categorized into two ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses